---
figid: PMC7312818__ijms-21-03848-g003
figlink: pmc/articles/PMC7312818/figure/ijms-21-03848-f003/
number: Figure 3
caption: 'Role of miRNAs in the host–pathogen interaction. (A) Toll-like receptors
  (TLRs) engage with the pathogen-associated molecular patterns (PAMP) and activate
  the transcription factor nuclear factor-κB (NF-κB) in the host cell. (B) miRNA directly
  targets the mRNA of retroviruses in host cells. (C) miRNA participates in defense
  mechanisms and targets the genomic replication of viral DNA. (D) LPS inhibits miR-149,
  a direct inhibitor of MyD88, allowing activation of inflammation via the MyD88/IRAK/TRAF6
  signaling pathway and expression of IL-8 in the CF airway. (E) Viral stimulated
  miR-144 and miR-146a target the TRAF6 signaling pathway to counteract the interferon
  defense responses in the human airway. (F) miRNA activated by NF-κB targets proteins
  that inhibit the PI3K/Akt signaling pathway to activate inflammation via IL-8. (G)
  Immune cells such as T helper cells can increase the expression of miRNAs against
  viral mRNA as defense mechanisms. (H) miRNA can also be transported from one cell
  to other cells through extracellular vesicles and could target ion channel proteins
  such as CFTR (I). ACE2: Angiotensin-converting enzyme-2; SARS-CoV-2: Severe acute
  respiratory syndrome coronavirus 2; PAMPs: Pathogen-associated molecular patterns;
  TLRs: Toll-like receptors; LPS: Lipopolysaccharide; NF-κB: nuclear factor-κB; MyD88:
  Myeloid differentiation primary response 88; IRAK: interleukin-1 receptor-associated
  kinase; TRAF6: tumor necrosis factor receptor-associated factor 6; H1N1: A subtype
  of Influenza A virus; HIV: Human immunodeficiency virus; miR/miRNA: micro RNA; mRNA:
  messenger RNA; IL-8: Interleukin-8; CFTR: Cystic fibrosis transmembrane conductance
  regulator; CD4: Cluster of differentiation 4; PI3K: Phosphoinositide 3-kinases;
  Akt: Protein kinase B (a serine/threonine-specific protein kinase).'
pmcid: PMC7312818
papertitle: The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
reftext: Nilay Mitash, et al. Int J Mol Sci. 2020 Jun;21(11):3848.
pmc_ranked_result_index: '70707'
pathway_score: 0.9125399
filename: ijms-21-03848-g003.jpg
figtitle: Role of miRNAs in the host–pathogen interaction
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7312818__ijms-21-03848-g003.html
  '@type': Dataset
  description: 'Role of miRNAs in the host–pathogen interaction. (A) Toll-like receptors
    (TLRs) engage with the pathogen-associated molecular patterns (PAMP) and activate
    the transcription factor nuclear factor-κB (NF-κB) in the host cell. (B) miRNA
    directly targets the mRNA of retroviruses in host cells. (C) miRNA participates
    in defense mechanisms and targets the genomic replication of viral DNA. (D) LPS
    inhibits miR-149, a direct inhibitor of MyD88, allowing activation of inflammation
    via the MyD88/IRAK/TRAF6 signaling pathway and expression of IL-8 in the CF airway.
    (E) Viral stimulated miR-144 and miR-146a target the TRAF6 signaling pathway to
    counteract the interferon defense responses in the human airway. (F) miRNA activated
    by NF-κB targets proteins that inhibit the PI3K/Akt signaling pathway to activate
    inflammation via IL-8. (G) Immune cells such as T helper cells can increase the
    expression of miRNAs against viral mRNA as defense mechanisms. (H) miRNA can also
    be transported from one cell to other cells through extracellular vesicles and
    could target ion channel proteins such as CFTR (I). ACE2: Angiotensin-converting
    enzyme-2; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; PAMPs:
    Pathogen-associated molecular patterns; TLRs: Toll-like receptors; LPS: Lipopolysaccharide;
    NF-κB: nuclear factor-κB; MyD88: Myeloid differentiation primary response 88;
    IRAK: interleukin-1 receptor-associated kinase; TRAF6: tumor necrosis factor receptor-associated
    factor 6; H1N1: A subtype of Influenza A virus; HIV: Human immunodeficiency virus;
    miR/miRNA: micro RNA; mRNA: messenger RNA; IL-8: Interleukin-8; CFTR: Cystic fibrosis
    transmembrane conductance regulator; CD4: Cluster of differentiation 4; PI3K:
    Phosphoinositide 3-kinases; Akt: Protein kinase B (a serine/threonine-specific
    protein kinase).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACE2
  - CXCL8
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - IRF6
  - AKT2
  - AKT3
  - AKT1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - CFTR
  - MYD88
  - TRAF6
  - CD4
  - SARS-COV-2
genes:
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: ActivatesPI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ActivatesPI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ActivatesPI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CFTR
  symbol: CFTR
  source: hgnc_symbol
  hgnc_symbol: CFTR
  entrez: '1080'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: CD4
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
chemicals: []
diseases:
- word: SARS-COV-2
  source: MESH
  identifier: D045169
---
